Pharma Trials World India 2010

• Brand your publication with an event that the industry believes in
• Fully capitalise on our integrated marketing campaign
• Increased customer contact and business opportunities
• Wider exposure to Indian and international organisations
• An unique opportunity to give clients “hands on” experience with your products / services
• Garner exclusive interview with the region’s movers and shakers
• Avail yourself of invaluable editorial & feature content at the conference

Call Yeeling Chua at +65 6322 2757 for more information on media partnership or endorsement opportunities or email her at yeeling.chua@terrapinn.com.

Our Media Partners..
 

Official business newspaper:

The Wall Street Journal Asia, established in 1976, has been voted the most "important business reading" among international daily newspapers in Asia in every ABRS/BE:ASIA study since the survey's inception in 1985. The Journal's China staff won a Pulitzer Prize in 2007 for coverage of the consequences of the nation's growth. The paper is edited and published in Hong Kong, and printed in eleven Asian cities. More than 75% of its subscribers are Asian. The Journal’s Web site for Asia is at www.asia.wsj.com and homepage for India is at www.india.wsj.com. The Wall Street Journal is also published online in Japanese at www.japan.wsj.com and in Chinese at www.chinese.wsj.com

International marketing partner:

Global Information, Inc. (GII)was established in Tokyo, Japan in 1984, and has since emerged as the single most successful aggregator for premium business intelligence and market research products in the Eastern hemisphere, and around the world. With offices in Korea, Singapore, Taiwan, Brussels, and the United States, we have expanded our client base and provide continuous 24 hour service around the globe. GII's experience and proactive marketing philosophy have allowed GII to develop key relationships with suppliers and customers, and provide our clients with the highest quality business intelligence available.  Please visit our portal site http://www.the-infoshop.com/ for more information.

  

Media partners:

BioCentury publishes BioCentury: The Bernstein Report on BioBusiness, a weekly business journal that provides independent coverage and analysis of biopharma industry developments. In addition, BioCentury publishes the BioCentury Extra, a daily recap of breaking industry events monitored throughout the day. The company also markets BCIQ: BioCentury Online Intelligence its biopharma-dedicated data solutions resource comprised of company profiles, financings and pipeline analysis. SciBX: Science-Business eXchange is a weekly journal published in collaboration with Nature Publishing Group that examines commercially promising translational science selected each week from research journals around the globe. For more information, visit www.biocentury.com and www.scibx.com.

 

BioPharm International integrates the science and business of biopharmaceutical research and development, and production/manufacturing. The magazine provides peer-reviewed technical solutions to enable biopharmaceutical R&D, manufacturing, process, lab, clinical, engineering and business professionals to confront work challenges. BioPharm International is the longest-running peer-reviewed publication serving an audited global audience of 29,245 BPA-qualified professionals involved in the development and manufacturing of therapeutics and management of related business issues. With the largest US readership in the biopharmaceutical market, BioPharm reaches a large universe of leading biotech and pharmaceutical companies, giving solution providers direct access to the core purchasing power of the biopharmaceutical industry.

Bio Spectrum is India's first monthly comprehensive Biotech business magazine covering the entire happenings in the exciting areas of BioPharma, BioAgriculture,BioInformatics, BioIndustrial, BioSuppliers and BioServices . BioSpectrum has columns by India's top policy makers, biotechnology professionals, scientists and NGOs and show cases the emerging Indian entrepreneurship in biotechnology. BioSpectrum reaches over 40,000 key decision makers in the Pharma and Biotech industry. Readers of BioSpectrum are from among the key policy makers, Consultants, Fund managers, Key executives and the influencers in pharmaceutical / agricultural companies, research labs / educational institutes, the clinical research, clinical trials and contract manufacturing organizations and the industrial sectors besides other auxiliary sectors. BioSpectrum is already the “ Voice of Indian BT industry ” BioSpectrum has emerged as the most preferred forum to engage the Indian biotech community reaching out to 1,38,000 readers world wide.

Bio-Outsourcing Asia© provides a comprehensive view of outsourcing issues facing the biopharmaceutical and biomedical industries as partnerships are formed with India, China, Taiwan, Malaysia, and other emerging Asian markets. http://www.canbiotech.com/CBBOA.asp

CRO Asia © is a premium online media platform targeting pharmaceutical outsourcing industry namely contract research and manufacturing organizations (CROs and CMOs) based in Asia-Pacific regions.    CRO Asia's unique and innovative partnering approach is to present a wide variety of contract service providers in Asia-Pacific to a highly specialized audience of scientists, professionals and decision makers in pharmaceutical industry. Our objective is to forge potential collaborations and strategic partnerships between those two parties by using our unique marketing tools and quality communication services.    For more information, please visit us at http://www.croasia.net

European BioPharmaceutical Review (EBR) provides a dedicated platform of communication and information for the biopharmaceutical market across Europe, North America and the rest of the world. Each quarterly issue, 10,500 copies of the magazine are distributed to our specially-targeted readership with articles on the hottest topics written by eminent commentators from the biotech scene. www.samedanltd.com

Express Pharma is the new avatar of Express Pharma Pulse, one of the most reliable brands in pharmaceutical media for the past 15 years, published by one of the oldest and most respected media group in India, the Indian Express Group. The newfound dynamic nature of the marketplace has made pharmaceutical professional demand for market information and intelligent analysis that helps them develop a perspective about issues influencing their domain, the trends in the market, the risks and opportunities for their business. Most importantly, they need all of this in one place, in an easy–to–consume format. Express Pharma is a one-stop-solution for that.

Now in its 28th year, GEN retains its position as the most widely read biotechnology publication around the globe. GEN's international purview includes applied research through commercialization. Editorial content includes regulatory, strategic alliances and collaborations, clinical trials, corporate profiles, in-depth interviews with leaders in industry, academia, and government, instructive tutorials in drug discovery and bioprocessing to enhance research results, and new products that enable significant advances in bioscience R&D. Genetic Engineering & Biotechnology News (GEN), the only high-frequency publication dedicated to biotech news, was introduced in 1981, as the first biotechnology trade publication. GEN is now the most widely read bionews publication worldwide. GEN's unique news editorial mandate is the entirety of the bioproduct life cycle, from early-stage R&D, to applied research and bioprocess, through to commercialization, including marketing and regulatory. GEN is the only publication with this mandate, covering the entirety of commercial bioscience: biopharmaceuticals, bio-agriculture, chemicals and enzymes, and environmental markets, and emerging biosciences including biodefense, bioenergy, and nanobiotechnology. GEN has from the beginning fused industry, academia and government, to foster industry collaborations and agreements.

GBI (www.gbipharma.com) is China’s leader in pharmaceutical and biotechnology information. GBI provides in-depth analysis and insights that enable subscribers to stay ahead of China’s pharmaceutical, biotechnology and healthcare industries. Our offerings include: -Weekly Roundup - Free weekly updates on industry news, signup on www.gbipharma.com -China Pharmaceutical & Biotechnology (CPB) Review - China's premier monthly magazine examining the latest industry trends -SOURCE Information Platform - Revolutionary service adding value to every aspect of a pharmaceutical organization

WHAT IS GOBALTO? goBalto is a web-based collaboration tool for the pharmaceutical and biotech industry. WHAT'S NEW? Now it's easier than ever to find and connect with colleagues in drug development and manufacturing. - NEW! Member Profile: Showcase your unique professional identity online - NEW! Contacts: Stay informed about your contacts - NEW! Activity Feed: Highlights profile changes and notifications - NEW! Status: Inform colleagues of whereabouts and actions - NEW! Profile Views: See how many times your profiles have been viewed MORE FEATURES - Partners: Search over 8,500 listings, including Pharma/Biotech, Generic Suppliers, CROs, Investigator Sites, CMOs, Consultants, and more! - Opportunities: Discover jobs and alliance opportunities - Answers: Get Answers from Industry Experts - Resources: Access research reports, presentations and white-papers - Collections: Build custom collections of Partners - Ratings: Read reviews and rate Partners - e-Tools: Automatically generate and distribute SFQs, RFIs, RFPs to multiple Partners (Coming Soon!) SIGN UP NOW AND GET CONNECTED WITH COLLEAGUES Build your unique member profile and showcase your expertise to the global drug development community. Plus, you can stay current on all things pharma through your Activity Feed. Signup and build your Free profile today! See you on the site! — Team goBalto Sign up for Free Account - http://www.gobalto.com/signup/?lpb=partner --------------------------- Our Users Are Saying: ""goBalto has identified an undeveloped niche in any development program that relies on hard to find external resources."" - Robert Michalik, Esq, Graduate School Lecturer at Northeastern University"

Innovaro Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Innovaro Pharmalicensing utilizes the unique Partnering Search service and its global network of industry experts to enable companies to identify and engage with appropriate partners around the world. Innovaro Pharmalicensing, and its newly launched sister service Innovaro Medical Device Licensing (www.medicaldevicelicensingcom) are actively utilized by over 190,000 industry professionals each month. Innovaro Pharmalicensing is part of Innovaro Corporation, listed on AMEX (INV).

JAIC Asia Bio Network (JABN) is an on-line service platform which provides information sharing and business collaboration opportunities to enhance the biomedical business ties between Japan and Asia.  JABN Japanese site provides industry news, company and product information, business partnering opportunities in Japanese with a focus on overseas market, whereas the English site provides similar information in English with a focus more on Japanese market.  We also provide customized consulting services to meet specific needs.  Please visit http://www.apbiotech-japan.com   or send email to sales@apbiotech-japan.com  for enquiry.

LabRoots is a free, social networking site that enables scientists, engineers, and other technical professionals to connect, collaborate with, and learn from each other. LabRoots fosters world-wide scientific communication and incorporates the newest social networking technologies. LabRoots allows scientists to connect with each other as they describe their research interests on a myriad of unique features and tools, discovering meaningful collaborations across geographic boundaries and fields of expertise. More than any other social networking site, LabRoots enables scientists to expand their circle of influence by providing their opinions, answers to other's questions, and other information. Additionally, LabRoots offers scientists the ability to receive highly targeted up-to-the minute news of scientific discoveries and advancements in their field along with the latest employment opportunities. LabRoots has the tools, audience, and content to be the ultimate destination for scientists to disseminate original ideas and information and to stretch the boundaries of science.

Life Sciences Industry News (LSIN), the fortnightly newspaper enables the life science professionals to keep abreast of latest developments in the industry.  The objective is to create an effective medium to focus the products and services, which keep the life sciences industry, (Biotechnology, Pharmaceutical, Biomedical, Diagnostics and Healthcare.) move ahead. LSIN brings out news, reports, features, updates, tutorials, commentaries etc under sections ‘Business & Market’ ‘Technology Trends’ ‘Research & Developments’. The target readers are middle level and senior level managers, scientists, and other professionals . The copies are distributed through post/ seminars/exhibitions and industry events For more information:www.lsin.in.

MarketsandMarkets is a full service and consulting firm that produces strategically analyzed full length reports track more than 10 industries. By FYE 2010 M&M plans to launch industry-wise and country wise market tracker for all the verticals tracked. This intelligence database comprising of about 60000 reports a year will form one of the world's largest intelligence resources worldwide. MarketsandMarkets has effectively used technology to automate management of large and complex data for forecasts. MarketsandMarkets aspires to help its client to achieve sustainable growth by providing incisive business insights into their respective business partners. Our 200 global strategic accounts with topline revenues in excess of USD 1 Billion annually. Delivered syndicated research studies to top publishers globally on a subcontracting model. The major industries that we cover in our market intelligence deliverables are Pharma & Biotech, Telecom & IT, Healthcare & Life sciences, Chemical & Advanced Material, Electronics & Semiconductor, Foods & Beverages.

Nature India: The one-stop site for information on Indian science. Serving the scientific community of the world’s largest democracy, it is replete with information on jobs, events, the best research and science news, in-depth features and commentaries from India. www.nature.com/natureindia. Also connecting with Indian scientists across the world through the throbbing Nature India forum (http://network.nature.com/groups/natureindia) and our very own Indigenus blog (http://blogs.nature.com/indigenus/).

PharmaAsia provides insights on how market trends and demographic changes offer opportunities to expanding pharmaceutical companies. It is equipped with an array of topics from biomarkers, pharmacovigilance, personalized medicine, data management, clinical trials management, cold chain management, automation to information technology. PharmaAsia is the leading resource for professionals looking to stay abreast of key issues impacting drug discovery, drug development and production. Published in both print and digital formats, PharmaAsia reaches over 6,000 qualified readers. Its website www.PharmaAsia.com is updated on a regular basis to keep readers up-to-date with the latest happenings in the industry and a weekly e-newsletter provides subscribers a convenient snapshot delivered right to their desktops.

Pharma Focus Asia is a bi-annual magazine from Ochre Media Pvt. Ltd. Pharma Focus Asia covers important issues and trends shaping the future of the Pharma industry across Asia and rest of the world. It is the leading Pharma title in print as well as digital versions serving the information needs of key executives from the world’s leading pharmaceutical companies.

Pharma China (www.pharmachinaonline.com) is the most influential English media and source of business intelligence covering the Chinese pharmaceutical / biopharmaceutical industry and market.  Pharma China caters for the growing needs of the international pharmaceutical industry for up-to-date and insightful information and intelligence on China’s burgeoning but increasingly complex healthcare marketplace, and is subscribed by most multinational pharmaceutical companies, leading CROs, investment banks and consulting firms active in China as well as relevant industry associations and government agencies. Pharma China Journal Edition (monthly in PDF and Print) Pharma China Web Edition (continuously-updated news, in-depth commentaries and online databases)  China Pharmaceutical Guide (the most comprehensive and authoritative reference for China’s healthcare sector)  SNAPI - Database-driven Sino-API Intelligence (the only reliable database of Chinese API products and producers

The World IP Reviews bi-monthly edition is dedicated to the needs of professionals involved in the management and protection of IP assets. It informs and educates IP owners and their international legal counsel and consultants of the latest strategies for managing, protecting and profiting from their increasingly valuable intellectual property. Each issue of the World IP Reviews bi-monthly edition will contain unique interviews with some of the most prominent IP owners and in-house counsel. It will use a combination of articles and case studies to showcase business strategies. In addition, it will review case law and IP legislation worldwide. To subscribe email subscriptions@worldipreview.com or please visit www.worldipreview.com where you can also view our annual Life Sciences IP Review for 2010.